Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01810484
Other study ID # ULT-133
Secondary ID
Status Completed
Phase N/A
First received March 8, 2013
Last updated January 30, 2018
Start date January 2013
Est. completion date January 2015

Study information

Verified date January 2015
Source Merz North America, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Up to 20 subjects will be enrolled. Enrolled subjects will receive one of three study treatments in the abdominal region: Ultherapy® only, Ultherapy® and CO2 laser treatment, or CO2 laser treatment only. Follow-up visit will occur at 14, 90 and 180 days post-treatment. Study images will be obtained pre-treatment, approximately 30 minutes post-treatment, and at each follow-up visit.


Description:

This is a prospective, randomized, single-blinded, pilot clinical trial to evaluate the use of the Ulthera® System in combination with the 70W Alma Pixel CO2 laser for efficacious results in the treatment of abdominal striae rubra and striae alba. Subjects will be randomized to one of three treatment groups. Study personnel conducting efficacy measures will be blinded to the assigned treatment groups.

Changes from baseline in overall skin texture and appearance of abdominal striae will be assessed at study follow-up visits. 2D images, 3D images and patient satisfaction questionnaires will be obtained.


Recruitment information / eligibility

Status Completed
Enrollment 14
Est. completion date January 2015
Est. primary completion date November 2014
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 21 Years to 65 Years
Eligibility Inclusion Criteria:

- Male or female, aged 21 to 65 years.

- Subject in good health.

- Fitzpatrick skin classification type 1-5.

- Striae rubra and alba on the abdomen.

- Understands and accepts the obligation not to undergo any other procedures in the area(s) to be treated through the follow-up period.

- Willingness and ability to comply with protocol requirements, including returning for follow-up visits and abstaining from exclusionary procedures for the duration of the study.

- Absence of physical or psychological conditions unacceptable to the investigator.

- Willingness and ability to provide written consent for study-required photography and adherence to photography requirements .

- Willingness and ability to provide written informed consent and HIPAA authorization prior to performance of any study-related procedure.

- Subjects of childbearing potential must have a negative urine pregnancy test result and must not be lactating at Visit 1 and be willing and able to use an acceptable method of birth control during the study

Exclusion Criteria:

- Presence of an active systemic or local skin disease that may affect wound healing.

- Current bacterial or viral infection in the area to be treated.

- Severe solar elastosis.

- Significant scarring or burns in area(s) to be treated.

- Prior radiation therapy in the area(s) to be treated.

- Open wounds or lesions in the area(s) to be treated.

- History of keloid or hypertrophic scarring

- History of irregular pigmentation of the skin, Lichens Planus, Vitiligo or Psoriasis in the treatment area that in the investigators opinion, would put the subject at unnecessary risk.

- Inability to understand the protocol or to give informed consent.

- Microdermabrasion, or prescription level glycolic acid treatments to the intended treatment area(s) within two weeks prior to study participation or during the study.

- History of chronic drug or alcohol abuse.

- History of autoimmune disease.

- Concurrent therapy that, in the investigator's opinion, would interfere with the evaluation of the safety or efficacy of the study device.

- Subjects who anticipate the need for surgery or overnight hospitalization during the study.

- Subjects who, in the investigator's opinion, have a history of poor cooperation,noncompliance with medical treatment, or unreliability.

- Concurrent enrollment in any study involving the use of investigational devices or drugs.

- Current smoker or history of smoking in the last five years.

- History of prior abdominal Suction Assisted Lipectomy or Abdominoplasty.

- History of prior Massive Weight Loss

- History of using the following prescription medications:

1. Accutane or other systemic retinoids within the past 12 months;

2. Antiplatelet agents / Anticoagulants (Coumadin, Heparin, Plavix);

3. Psychiatric drugs that in the investigators opinion would impair the subject from understanding the protocol requirements or understanding and signing informed consent.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Ultherapy® treatment only
Focused ultrasound energy delivered below the surface of the skin
Ultherapy® treatment and CO2 laser treatment
Ultherapy® treatment: Focused ultrasound energy delivered below the surface of the skin; CO2 Laser: Fractionated energy delivered to the surface of the skin for ablative and thermal injury to the skin layers for resurfacing the skin.
CO2 Laser treatment only
CO2 Laser: Fractionated energy delivered to the surface of the skin for ablative and thermal injury to the skin layers for resurfacing the skin.

Locations

Country Name City State
United States Dermatology, Laser & Vein Specialists of the Carolinas Charlotte North Carolina
United States Art Plastic Surgery Paramus New Jersey

Sponsors (1)

Lead Sponsor Collaborator
Ulthera, Inc

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from baseline in overall skin texture and appearance of abdominal striae A masked, qualitative assessment of change from baseline in the areas treated based a review of 2D images obtained at baseline and 90 days post-treatment. 90-days post-treatment
Secondary 90 Day Patient Satisfaction Based on completion of Patient Satisfaction Questionnaires 90 Days post-treatment
Secondary 180 Day Patient Satisfaction Based on completion of Patient Satisfaction Questionnaires 180 Days post-treatment
Secondary Change from baseline in overall aesthetic appearance of abdominal striae at 90 days Assessment of change in overall aesthetic appearance of abdominal striae from baseline to 90 days post-treatment based on review of pretreatment and 90 day post-treatment 2D images and a live assessment of the treatment area 90 Days post-treatment
Secondary Change from baseline in overall aesthetic appearance of abdominal striae at 180 days Assessment of change in overall aesthetic appearance of abdominal striae from baseline to 180 days post-treatment based on review of pretreatment and 180 day post-treatment 2D images and a live assessment of the treatment area 180 Days post-treatment
Secondary Change from baseline in skin striae texture and depth at 90 Days Quantitative analysis will be completed comparing 3D images obtained at baseline to 3D images obtained at 90 days post-treatment. 90 Days post-treatment
Secondary Change from baseline in skin striae texture and depth at 180 Days Quantitative analysis will be completed comparing 3D images obtained at baseline to 3D images obtained at 180 days post-treatment. 180 Days post-treatment
See also
  Status Clinical Trial Phase
Completed NCT04806594 - Clinical Investigation on the Safety and Clinical Performance of Papix Acne Scar. N/A
Completed NCT01700595 - Preexpanded Perforator Flaps in Children N/A
Recruiting NCT03782038 - Study to Evaluate the Efficacy of a Micro Coring Device for the Treatment of Scars of the Cytrellis Micro-Coring Device for the Treatment of Scars N/A
Recruiting NCT06202274 - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology N/A
Not yet recruiting NCT02590042 - Safety of Adipose-Derived Stem Cell Stromal Vascular Fraction Phase 1
Completed NCT01932359 - Rapidly Absorbable Versus Non-absorbable Sutures for Mohs Surgery Repair on the Face: a Randomized Controlled Split-scar Study N/A
Unknown status NCT00969475 - The Effects of Fractional Carbon Dioxide (CO2) Laser Treatment Prior to Wound Closure N/A
Completed NCT01091181 - The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar N/A
Recruiting NCT06021275 - Microneedling With Regular Insulin Versus Microneedling Alone in Treatment of Atrophic Scars N/A
Recruiting NCT02195063 - Survey Study for Pain Management, Wound Care, Scar Care or UDT Phase 4
Terminated NCT00803140 - Cutaneous Scarring of Scalpel Versus Cautery N/A
Not yet recruiting NCT04593706 - Comparison of the Efficacy of Different Steroids in the Treatment of Abnormal Scars (Keloids, Hypertrophic Scars) N/A
Recruiting NCT05847530 - Pilot Evaluation of the Cynosure Potenza™ System for Treatment of Cosmetic Dermatologic Skin Conditions N/A
Withdrawn NCT01350739 - The Umbilical Access in Laparoscopic Surgery N/A
Completed NCT02145130 - Phase I Study for Autologous Dermal Substitutes and Dermo-epidermal Skin Substitutes for Treatment of Skin Defects Phase 1
Completed NCT01358838 - Ablative 10600 nm Fractional Laser Therapy for the Treatment of Scars N/A
Completed NCT03880058 - Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance Phase 1/Phase 2
Recruiting NCT05528328 - Post-surgical Scars After the Use of CACIPLIQ20 Phase 3
Completed NCT00450775 - Evaluation of the Efficacy, Tolerability, and Patient Acceptance of Dermatix Q for the Prevention and Management of Scars Phase 4
Completed NCT00580736 - Optical Clearing of the Skin in Conjunction With Laser Treatments Phase 1